Ketamine and HTLV-1 myelopathy: NMDA blockade and immunomodulation?
Prommer
Eric
E
D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D015490:HTLV-I Infections / Q000188:drug therapy* / Q000276:immunology; D015368:Human T-lymphotropic virus 1; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology; D007649:Ketamine / Q000494:pharmacology*; D010146:Pain / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D013118:Spinal Cord Diseases / Q000276:immunology / Q000821:virology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000821:virology
D018691:Excitatory Amino Acid Antagonists; D007155:Immunologic Factors; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine